Literature DB >> 19322906

Indoleamine 2,3-dioxygenase in intestinal immunity and inflammation.

Bobby J Cherayil1.   

Abstract

Indoleamine 2,3-dioxygenase (IDO) is a tryptophan catabolizing enzyme that has a number of immunoregulatory effects. It is expressed at high levels in the gastrointestinal tract, particularly in the small intestine, and has been implicated in the control of intestinal inflammation. However, its precise role in intestinal immunity is not well understood. This review will summarize the current state of knowledge about IDO function, particularly as it pertains to inflammatory responses in the gut.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19322906     DOI： 10.1002/ibd.20910

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN： 1078-0998            Impact factor:   5.325


  29 in total

Review 1.  Indoleamine 2,3-dioxygenase as a modifier of pathogenic inflammation in cancer and other inflammation-associated diseases.

Authors:  G C Prendergast; M Y Chang; L Mandik-Nayak; R Metz; A J Muller
Journal:  Curr Med Chem       Date:  2011       Impact factor: 4.530

2.  IDO in human gut graft-versus-host disease.

Authors:  Philippe Ratajczak; Anne Janin; Régis Peffault de Larour; Lisa Koch; Brigitte Roche; David Munn; Bruce R Blazar; Gérard Socié
Journal:  Biol Blood Marrow Transplant       Date:  2011-08-09       Impact factor: 5.742

3.  Tryptophan Metabolism through the Kynurenine Pathway is Associated with Endoscopic Inflammation in Ulcerative Colitis.

Authors:  M Anthony Sofia; Matthew A Ciorba; Katherine Meckel; Chai K Lim; Gilles J Guillemin; Christopher R Weber; Marc Bissonnette; Joel R Pekow
Journal:  Inflamm Bowel Dis       Date:  2018-06-08       Impact factor: 5.325

Review 4.  Potential roles of self-reactive T cells in autoimmunity: lessons from cancer immunology.

Authors:  Mads Hald Andersen
Journal:  Immunol Res       Date:  2014-12       Impact factor: 2.829

5.  Deficit, but Not Nondeficit, Schizophrenia Is Characterized by Mucosa-Associated Activation of the Tryptophan Catabolite (TRYCAT) Pathway with Highly Specific Increases in IgA Responses Directed to Picolinic, Xanthurenic, and Quinolinic Acid.

Authors:  Buranee Kanchanatawan; Sunee Sirivichayakul; Kiat Ruxrungtham; André F Carvalho; Michel Geffard; Heidi Ormstad; George Anderson; Michael Maes
Journal:  Mol Neurobiol       Date:  2017-02-08       Impact factor: 5.590

6.  A role of the aryl hydrocarbon receptor in attenuation of colitis.

Authors:  Keisuke Furumatsu; Shin Nishiumi; Yuki Kawano; Makoto Ooi; Tomoo Yoshie; Yuuki Shiomi; Hiromu Kutsumi; Hitoshi Ashida; Yoshiaki Fujii-Kuriyama; Takeshi Azuma; Masaru Yoshida
Journal:  Dig Dis Sci       Date:  2011-03-05       Impact factor: 3.199

7.  Increased density of tolerogenic dendritic cells in the small bowel mucosa of celiac patients.

Authors:  Tamara Vorobjova; Oivi Uibo; Kaire Heilman; Raivo Uibo
Journal:  World J Gastroenterol       Date:  2015-01-14       Impact factor: 5.742

8.  Circulating Zonulin Correlates with Density of Enteroviruses and Tolerogenic Dendritic Cells in the Small Bowel Mucosa of Celiac Disease Patients.

Authors:  Tamara Vorobjova; Helerin Raikkerus; Lumme Kadaja; Ija Talja; Oivi Uibo; Kaire Heilman; Raivo Uibo
Journal:  Dig Dis Sci       Date:  2016-12-19       Impact factor: 3.199

Review 9.  Indoleamine 2,3 dioxygenase in intestinal disease.

Authors:  Matthew A Ciorba
Journal:  Curr Opin Gastroenterol       Date:  2013-03       Impact factor: 3.287

10.  IgA/IgM responses to tryptophan and tryptophan catabolites (TRYCATs) are differently associated with prenatal depression, physio-somatic symptoms at the end of term and premenstrual syndrome.

Authors:  Chutima Roomruangwong; Buranee Kanchanatawan; Sunee Sirivichayakul; George Anderson; André F Carvalho; Sebastien Duleu; Michel Geffard; Michael Maes
Journal:  Mol Neurobiol       Date:  2016-04-01       Impact factor: 5.590
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.